Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RET proto-oncogene encodes a receptor tyrosine kinase essential for neural crest-derived cell development, urogenital system formation, and nervous system development. It acts as a receptor for GDNF family ligands, requiring GFRα co-receptors. RET activation triggers MAPK, PI3K/AKT, and JAK/STAT pathways, regulating gene expression related to growth, survival, migration, and differentiation. Mutations in RET are associated with developmental disorders like Hirschsprung's disease and cancers such as multiple endocrine neoplasia and thyroid carcinoma, making it a therapeutic target for selective small-molecule inhibitors.
Inhibition of RET kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RET Proto-oncogene Protein (RET).